These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8907069)

  • 1. Cyclosporine, FK-506, rapamycin, and other immunomodulators.
    Yocum DE
    Rheum Dis Clin North Am; 1996 Feb; 22(1):133-54. PubMed ID: 8907069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of immunomodulators in early rheumatoid arthritis.
    Yocum DE
    Semin Arthritis Rheum; 1994 Jun; 23(6 Suppl 2):44-9. PubMed ID: 7939731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation.
    Markus PM; Cai X; Selvaggi G; Cooper M; Harnaha J; Fung JJ; Starzl TE
    Transplant Proc; 1991 Dec; 23(6):3232-3. PubMed ID: 1721418
    [No Abstract]   [Full Text] [Related]  

  • 4. Porcine small bowel transplantation with rapamycin-based induction immunosuppression and short-course cyclosporine or FK 506 therapy.
    Cohen DS; Fisher RA; Shapiro JH; Goggins WC; Tawes JW; Mills S; Contos M; Ham JM; Schroeder TJ
    Transplant Proc; 1996 Oct; 28(5):2501-5. PubMed ID: 8907923
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative study of toxicity and efficacy of cyclosporine, cyclosporine G (OG37), FK 506, and rapamycin in BALB/c mice with fitted skin grafts.
    Masri MA
    Transplant Proc; 1995 Feb; 27(1):366. PubMed ID: 7533412
    [No Abstract]   [Full Text] [Related]  

  • 6. FK 506 versus cyclosporine A for steroid-free synergistic combination therapy with rapamycin in a discordant large animal donor xenoislet transplant model.
    Troppmann C; Papalois BE; Gruessner AC; Nakhleh RE; Gruessner RW
    Transplant Proc; 1997; 29(1-2):914-5. PubMed ID: 9123585
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis.
    Kitahara K; Kawai S
    Curr Opin Rheumatol; 2007 May; 19(3):238-45. PubMed ID: 17414949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein and drug resistance in systemic autoimmune diseases.
    Picchianti-Diamanti A; Rosado MM; Scarsella M; Laganà B; D'Amelio R
    Int J Mol Sci; 2014 Mar; 15(3):4965-76. PubMed ID: 24658440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sub-therapeutic doses of sirolimus and cyclosporin A in combination reduce SLE pathologies in the MRL mouse.
    Warner LM; Cummons T; Nolan L; Sehgal SN
    Inflamm Res; 1995 Aug; 44 Suppl 2():S205-6. PubMed ID: 8548401
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo immunopharmacology of the macrolides FK 506 and rapamycin: toward the era of rational immunosuppressive drug discovery, development, and use.
    Morris RE
    Transplant Proc; 1991 Dec; 23(6):2722-4. PubMed ID: 1721257
    [No Abstract]   [Full Text] [Related]  

  • 11. FK-506 (tacrolimus) therapy for an unusual SLE-like disease.
    Kilian K; Banyai A; Karadi A; Miklos K; Patranyi GG; Paloczi K
    Transplant Proc; 1998 Dec; 30(8):4130-1. PubMed ID: 9865322
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine in the treatment of autoimmune disorders: a 10-year experience.
    Mitrovic D; Popovic M; Glisic B; Pavlica L; Dimitrijevic M
    Transplant Proc; 1998 Dec; 30(8):4134. PubMed ID: 9865324
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine, FK-506 and other drugs in organ transplantation.
    Morris PJ
    Curr Opin Immunol; 1991 Oct; 3(5):748-51. PubMed ID: 1721824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antimicrobial activities of cyclosporine, FK506, and rapamycin.
    High KP
    Transplantation; 1994 Jun; 57(12):1689-700. PubMed ID: 7517076
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of long-term immunosuppression for limb transplantation using cyclosporine, tacrolimus, and mycophenolate mofetil: implications for clinical composite tissue transplantation.
    Jones NF; Hebebrand D; Buttemeyer R; Zhao M; Benhaim P; Rao U
    Plast Reconstr Surg; 2001 Mar; 107(3):777-84. PubMed ID: 11304605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of orally administered rapamycin in animal models of arthritis and other autoimmune diseases.
    Carlson RP; Baeder WL; Caccese RG; Warner LM; Sehgal SN
    Ann N Y Acad Sci; 1993 Jun; 685():86-113. PubMed ID: 8363289
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunosuppressive agents in chronic severe asthma.
    Kay AB
    Allergy Proc; 1994; 15(3):147-50. PubMed ID: 7523242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance pharmacological immunosuppressive strategies in renal transplantation.
    Vella JP; Sayegh MH
    Postgrad Med J; 1997 Jul; 73(861):386-90. PubMed ID: 9338020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic monitoring of cyclosporine, FK-506, and rapamycin.
    Yatscoff RW; Shaw LM
    Ther Drug Monit; 1992 Aug; 14(4):267-8. PubMed ID: 1381530
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical use of FK 506 in liver transplantation.
    Klintmalm GB
    Transplant Proc; 1996 Apr; 28(2):974-6. PubMed ID: 8623484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.